Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
12.39
+0.17 (1.39%)
At close: Sep 8, 2026, 4:00 PM EDT
12.61
+0.39 (3.22%)
Pre-market: Sep 9, 2026, 8:45 AM EDT
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
905.22M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 450.89M |
| Rigel Pharmaceuticals | 276.79M |
| Theravance Biopharma | 104.31M |
| Crescent Biopharma | 11.88M |
| Aclaris Therapeutics | 8.22M |
HELP News
- 1 hour ago - Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York - GlobeNewsWire
- 6 days ago - Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York - GlobeNewsWire
- 20 days ago - Helus Pharma price target raised to $62 from $8 at TD Cowen - TheFly
- 22 days ago - Helus Pharma appoints Regina Donohue as chief people officer - TheFly
- 22 days ago - Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board - GlobeNewsWire
- 25 days ago - Cybin Earnings release: Q1 2027 - Filings
- 26 days ago - Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights - GlobeNewsWire
- 27 days ago - Cybin Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts